Center François Baclesse / Centre Régional de Lutte contre le Cancer François Baclesse (CRLCC)
Hospital
Location:
Caen,
France (FR)
ISNI: 000000121067843
ROR: https://ror.org/02x9y0j10
Carboplatin/pegylated liposomal doxorubicin/bevacizumab (CD-BEV) vs. carboplatin/gemcitabine/bevacizumab (CG-BEV) in patients with recurrent ovarian cancer: A prospective randomized phase III ENGOT/GCIG-Intergroup study (AGO study group, AGO-Austria, ANZGOG, GINECO, SGCTG) (2018)
Pfisterer J, Dean AP, Baumann K, Rau J, Harter P, Joly F, Sehouli J, et al.
Conference contribution
Diagnostic reproducibility of tumour budding in colorectal cancer: A multicentre, multinational study using virtual microscopy (2012)
Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, Pecori S, et al.
Journal article, Review article